Hannah Brendan

CBO, COO & CCO · 3 insider transactions on file

All transactions

Date	Ticker	Company	Type	Shares	Price	Value	Filing
2025-12-05	QNCX	Quince Therapeutics, Inc.	Option exercise	25,280	$0.94	$23,763.20	filing
2025-12-05	QNCX	Quince Therapeutics, Inc.	Option exercise	2,271	$0.55	$1,249.05	filing
2025-06-18	QNCX	Quince Therapeutics, Inc.	Award	37,736	$1.20	$45,283.20	filing

Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.